Winter Shortland Temple syndrome
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.
|
27236920 |
2016 |
Winter Shortland Temple syndrome
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.
|
27236920 |
2016 |
Winter Shortland Temple syndrome
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Winter Shortland Temple syndrome
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.
|
27236920 |
2016 |
Winter Shortland Temple syndrome
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.
|
27236920 |
2016 |
Winter Shortland Temple syndrome
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Medulloblastoma in a Patient with Curry-Jones Syndrome with a mosaic variant, c.1234C > T (p.Leu412Phe), in SMO.
|
31825089 |
2020 |
Winter Shortland Temple syndrome
|
0.710 |
SomaticCausalMutation
|
disease |
ORPHANET |
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.
|
27236920 |
2016 |
Winter Shortland Temple syndrome
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Identification of recurrent SMO and BRAF mutations in ameloblastomas.
|
24859340 |
2014 |
Winter Shortland Temple syndrome
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We report here the identification of activating somatic missense mutations in the SMO gene itself in sporadic BCCs from three patients.
|
9422511 |
1998 |
Carcinoma, Basal Cell
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Vismodegib.
|
22679179 |
2012 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Some tumors exhibiting hedgehog pathway activation such as basal cell cancer frequently harbor PATCHED-ONE (PTCH-1) or SMOOTHENED (SMO) gene mutations.
|
18543049 |
2008 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SMO gene have been identified in basal cell carcinoma and in medulloblastoma, both of which are features of NBCCS.
|
18502968 |
2008 |
Carcinoma, Basal Cell
|
0.700 |
Biomarker
|
disease |
CTD_human |
Two BCCs demonstrated mutations in both SMOH and PTCH.
|
9581815 |
1998 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Somatic SMO mutations have also been found in some basal cell carcinomas.
|
17214858 |
2007 |
Carcinoma, Basal Cell
|
0.700 |
Biomarker
|
disease |
CTD_human |
Eighty-five percent of the BCCs harbored mutations in Hh pathway genes (PTCH1, 73% or SMO, 20% (P = 6.6 × 10(-8)) and SUFU, 8%) and in TP53 (61%).
|
26950094 |
2016 |
Carcinoma, Basal Cell
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Smoothened variants explain the majority of drug resistance in basal cell carcinoma.
|
25759020 |
2015 |
Carcinoma, Basal Cell
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
|
19726788 |
2009 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations that occur in BCC in hedgehog (Hh) pathway genes primarily involve the genes encoding patched homolog (PTCH) and smoothened homolog (SMO).
|
25766766 |
2015 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The constitutive activation of the sonic hedgehog signaling pathway by acquired mutations in the PTCH and SMO genes appears to represent the early basal cell carcinoma developmental determinant.
|
25207369 |
2014 |
Carcinoma, Basal Cell
|
0.700 |
Biomarker
|
disease |
BEFREE |
Mutations in hedgehog signaling pathway genes, especially PTC1 and SMO, are pivotal to the development of basal cell carcinomas.
|
11348463 |
2001 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Other genotypes, such as the TT in SHH rs104894049 331 A/T and the GG in SMO rs41303402 rs41303402" genes_norm="5727;6608">385 G/A also statistically raised the risk of BCC, but these associations were weaker.
|
26590974 |
2016 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.
|
25306392 |
2015 |
Carcinoma, Basal Cell
|
0.700 |
Biomarker
|
disease |
BEFREE |
Interestingly, BCNS-BCCs are more responsive to SMO inhibitors than sporadic BCCs, with minimal development of resistance.
|
29111235 |
2018 |
Carcinoma, Basal Cell
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutational analysis identified four BCCs with somatic missense mutations in SMOH affecting codon 535 (TGG==>TTG: Trp==>Leu) in three tumors and codon 199 (CGG==>TGG: Arg==>Trp) in one tumor.
|
9581815 |
1998 |